|
|
Article: GENERICS INCURSION CAUSE A CYTOTOXIC MARKET DECLINE.
- Article from:
- Worldwide Biotech
- Article date:
- January 1, 2009
CopyrightCOPYRIGHT 2009 Worldwide Videotex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Cytotoxic therapy, or chemotherapy as it is commonly known, has been the cornerstone of cancer treatment for many years and involves the use of drugs that are toxic to all cells including those that are perfectly healthy. While relatively effective, this leads to the unpleasant side effects commonly associated with cytotoxic treatment, such as vomiting, nausea, alopecia and fatigue. Despite this, and the rise in prominence of targeted therapies, cytotoxics are used in almost all cancer types and as a result of this high volume of sales, make up the second largest selling class of cancer therapeutics. However, given the relative maturity of this therapeutic class, generics ...